Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. pregnancy. 2. evidence of severe acute respiratory infection, even if it meets the criteria for a suspected or confirmed case. 3. hepatic insufficiency 4. diseases that occur with immunosuppression or therapeutic immunosuppression. 5. heart diseases; controlled hypertension is allowed. 6. metabolic diseases; controlled diabetes mellitus is allowed. 7. individuals who have been treated with dle in the last 6 months. conave: national committee for epidemiological surveillance. indre: institute of epidemiological diagnosis and reference.

1. pregnancy. 2. evidence of severe acute respiratory infection, even if it meets the criteria for a suspected or confirmed case. 3. hepatic insufficiency 4. diseases that occur with immunosuppression or therapeutic immunosuppression. 5. heart diseases; controlled hypertension is allowed. 6. metabolic diseases; controlled diabetes mellitus is allowed. 7. individuals who have been treated with dle in the last 6 months. conave: national committee for epidemiological surveillance. indre: institute of epidemiological diagnosis and reference.

Nov. 16, 2021, 6:30 p.m. usa

pregnancy. evidence of severe acute respiratory infection, even if it meets the criteria for a suspected or confirmed case. hepatic insufficiency diseases that occur with immunosuppression or therapeutic immunosuppression. heart diseases; controlled hypertension is allowed. metabolic diseases; controlled diabetes mellitus is allowed. individuals who have been treated with dle in the last 6 months. conave: national committee for epidemiological surveillance. indre: institute of epidemiological diagnosis and reference.

pregnancy. evidence of severe acute respiratory infection, even if it meets the criteria for a suspected or confirmed case. hepatic insufficiency diseases that occur with immunosuppression or therapeutic immunosuppression. heart diseases; controlled hypertension is allowed. metabolic diseases; controlled diabetes mellitus is allowed. individuals who have been treated with dle in the last 6 months. conave: national committee for epidemiological surveillance. indre: institute of epidemiological diagnosis and reference.

Oct. 26, 2020, 11:31 p.m. usa

1. pregnancy. 2. evidence of severe acute respiratory infection, even if it meets the criteria for a suspected or confirmed case. 3. hepatic insufficiency 4. diseases that occur with immunosuppression or therapeutic immunosuppression. 5. heart diseases; controlled hypertension is allowed. 6. metabolic diseases; controlled diabetes mellitus is allowed. 7. individuals who have been treated with dle in the last 6 months. conave: national committee for epidemiological surveillance. indre: institute of epidemiological diagnosis and reference.

1. pregnancy. 2. evidence of severe acute respiratory infection, even if it meets the criteria for a suspected or confirmed case. 3. hepatic insufficiency 4. diseases that occur with immunosuppression or therapeutic immunosuppression. 5. heart diseases; controlled hypertension is allowed. 6. metabolic diseases; controlled diabetes mellitus is allowed. 7. individuals who have been treated with dle in the last 6 months. conave: national committee for epidemiological surveillance. indre: institute of epidemiological diagnosis and reference.